Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matti Vauhkonen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Best Practice & Research. Clinical Gastroenterology|September 26, 2006
Pathology and molecular biology of gastric cancerMatti Vauhkonen, Hanna Vauhkonen, Pentti Sipponen
Scandinavian Journal of Gastroenterology|December 17, 2008
Helicobacter pylori infection induces a reversible expression of the CDX2 transcription factor protein in human gastric epitheliumMatti Vauhkonen, Hanna Vauhkonen, Pentti Sipponen
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 6, 2005
Differences in genomic instability between intestinal- and diffuse-type gastric cancerMatti Vauhkonen, Hanna Vauhkonen, Antti Sajantila, et al.
Cancer Genetics and Cytogenetics|October 3, 2006
Characterizing genetically stable and unstable gastric cancers by microsatellites and array comparative genomic hybridizationHanna Vauhkonen, Matti Vauhkonen, Antti Sajantila, et al.
Cancer Genetics and Cytogenetics|June 2, 2006
DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridizationHanna Vauhkonen, Matti Vauhkonen, Antti Sajantila, et al.
World Journal of Gastroenterology|November 8, 2005
Low circulating levels of gastrin-17 in patients with Barrett's esophagusPentti Sipponen, Matti Vauhkonen, Timo Helske, et al.
Journal of Forensic Sciences|March 19, 2004
Typing of XY (male) genotype from malignant neoplastic tissue by the amelogenin-based sex testHanna Vauhkonen, Minttu Hedman, Matti Vauhkonen, et al.
Inflammatory Bowel Diseases|January 7, 2012
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agentsPauliina Molander, Clas-Göran af Björkesten, Harri Mustonen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Best Practice & Research. Clinical Gastroenterology|September 26, 2006
Pathology and molecular biology of gastric cancerMatti Vauhkonen, Hanna Vauhkonen, Pentti Sipponen
Scandinavian Journal of Gastroenterology|December 17, 2008
Helicobacter pylori infection induces a reversible expression of the CDX2 transcription factor protein in human gastric epitheliumMatti Vauhkonen, Hanna Vauhkonen, Pentti Sipponen
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 6, 2005
Differences in genomic instability between intestinal- and diffuse-type gastric cancerMatti Vauhkonen, Hanna Vauhkonen, Antti Sajantila, et al.
Cancer Genetics and Cytogenetics|October 3, 2006
Characterizing genetically stable and unstable gastric cancers by microsatellites and array comparative genomic hybridizationHanna Vauhkonen, Matti Vauhkonen, Antti Sajantila, et al.
Cancer Genetics and Cytogenetics|June 2, 2006
DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridizationHanna Vauhkonen, Matti Vauhkonen, Antti Sajantila, et al.
World Journal of Gastroenterology|November 8, 2005
Low circulating levels of gastrin-17 in patients with Barrett's esophagusPentti Sipponen, Matti Vauhkonen, Timo Helske, et al.
Journal of Forensic Sciences|March 19, 2004
Typing of XY (male) genotype from malignant neoplastic tissue by the amelogenin-based sex testHanna Vauhkonen, Minttu Hedman, Matti Vauhkonen, et al.
Inflammatory Bowel Diseases|January 7, 2012
Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agentsPauliina Molander, Clas-Göran af Björkesten, Harri Mustonen, et al.
Pageof 1